People with knee arthritis and type 2 diabetes who take GLP-1 drugs like semaglutide tend to lose a lot more weight—about 7 extra kilograms—over nearly 8 years compared to those not taking them, and many more of them achieve meaningful weight loss.

67

Pro

0

Against

Evidence from Studies

Supporting (1)

67

Community contributions welcome

67

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Cohort Study

Human

2023 Sep

The study looked at people with knee arthritis and diabetes who took GLP-1RAs and found they lost about 7.3 kg more than those who didn’t, which matches the claim.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Score: 67

DOI: 10.1136/ard-2023-223845

Similar Assertions

If you have diabetes and take GLP-1 drugs like Ozempic for five years, you might be more likely to develop hip or knee arthritis—even if you're not overweight. These meds help with blood sugar and weight, but this claim says they could also hurt your joints over time.

53

0

88%

People with knee arthritis and diabetes who take GLP-1 drugs like Ozempic seem to need knee surgery less often — 1.7% of them did over 6 years, compared to 5.9% who didn’t take the drugs — and some of this benefit comes from losing weight.

0

8

87%

For people with knee arthritis and type 2 diabetes, taking GLP-1 drugs (like Ozempic) may lower the chance of needing knee surgery — and about one-third of that benefit comes from losing weight, not just from better blood sugar control.

67

0

86%

People with knee arthritis and type 2 diabetes who take GLP-1 drugs (like Ozempic) may be less likely to need knee surgery—only 1.7% did, compared to 5.9% who didn’t take the drugs, over about 8 years.

67

0

83%

If someone with knee or joint pain loses more weight using GLP-1 drugs like Ozempic, they might feel less pain — and this could mean that getting healthier on a metabolic level helps ease joint symptoms.

1

0

82%